You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The FDA granted clearance to consumer genetic testing company Ancestry.com for the over-the-counter use of a health risk test for hereditary thrombophilia.
The Helsinki-based firm is making its panel available for free to people who already have been genotyped by consumer genomics services or biobanks.
The educational grant will support UpToDate's development of technology to help medical professionals advise their patients on health implications of genetic tests.
The company launched a "core" service using Illumina microarray genotyping, and has plans for an expanded NGS offering with Quest Diagnostics.
DNA Genotek alleged that Ancestry.com misappropriated its intellectual property related to saliva DNA collection kits.